Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?
J Hypertens
.
2019 May;37(5):902-904.
doi: 10.1097/HJH.0000000000002018.
Authors
Sverre E Kjeldsen
1
2
,
Ingrid Os
1
3
,
Arne Westheim
2
Affiliations
1
Faculty of Medicine, University of Oslo.
2
Department of Cardiology.
3
Department of Nephrology, Oslo University Hospital, Ullevaal, Oslo, Norway.
PMID:
30920495
DOI:
10.1097/HJH.0000000000002018
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antihypertensive Agents*
Blood Pressure / drug effects
Blood Pressure Determination*
Substances
Antihypertensive Agents